Hormone receptor positive (HR+) BC (defined as the expression of the oestrogen receptor (ER) or progesterone receptor (PR) or both) represents the most common subtype in younger patients, accounting for approximately two‐thirds of all BC cases [6]. Here, PGR is linked to breast cancer.